WOOTEN RONALD J

Exec Vice Pres,Corporate Devel at QUINTILES TRANSNATIONAL CORP · on record since Sep 17, 2003
Director at Revance Therapeutics, Inc. · on record since Feb 11, 2014
10% owner at Revance Therapeutics, Inc. · on record since Feb 11, 2014
Director at IDERA PHARMACEUTICALS, INC. · on record since Sep 30, 2022

Insider trading activity of WOOTEN RONALD J

Transactions on record: 39; since Sep 17, 2003

Open-market buys: 0

Open-market sells: 0

Companies traded: 3; last filing Jan 19, 2023

Figures computed from official regulatory filings — .

Companies where WOOTEN RONALD J has traded

IDERA PHARMACEUTICALS, INC.6 tx · Jan 19, 2023
Revance Therapeutics, Inc.10 tx · May 27, 2015
QUINTILES TRANSNATIONAL CORP23 tx · $10.4K · Sep 29, 2003

Track record of WOOTEN RONALD J

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of WOOTEN RONALD J

Co-insiders of WOOTEN RONALD J

14159 capital (GP), LLCIDERA PHARMACEUTICALS, INC.
14159, L.P.IDERA PHARMACEUTICALS, INC.
667, L.P.IDERA PHARMACEUTICALS, INC.
Abdul-Wahab UmariIDERA PHARMACEUTICALS, INC.
AGRAWAL SUDHIRIDERA PHARMACEUTICALS, INC.
Allouche CyrilRevance Therapeutics, Inc.
ANDERSEN ROBERT GIDERA PHARMACEUTICALS, INC.
Arbeit Robert D.IDERA PHARMACEUTICALS, INC.
Arcudi Louis J.IDERA PHARMACEUTICALS, INC.
Baker Biotech Capital (GP), LLCIDERA PHARMACEUTICALS, INC.
Baker Biotech Capital II (GP), LLCIDERA PHARMACEUTICALS, INC.
Baker Biotech Capital III (GP), LLCIDERA PHARMACEUTICALS, INC.
Baker Biotech Capital III (Z) (GP), LLCIDERA PHARMACEUTICALS, INC.
Baker Biotech Capital II (Z) (GP), LLCIDERA PHARMACEUTICALS, INC.
Baker Bros. Advisors (GP) LLCIDERA PHARMACEUTICALS, INC.
BAKER BROS. ADVISORS LPIDERA PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
IDERA PHARMACEUTICALS, INC.	Jan 19, 2023	OtherD (derivative)	830,294	—	—	SEC
IDERA PHARMACEUTICALS, INC.	Jan 19, 2023	OtherD (derivative)	-14,115	—	—	SEC
IDERA PHARMACEUTICALS, INC.	Sep 30, 2022	OtherD (derivative)	14,115	—	—	SEC
IDERA PHARMACEUTICALS, INC.	Sep 30, 2022	Other	5	—	—	SEC
IDERA PHARMACEUTICALS, INC.	Sep 30, 2022	OtherD (derivative)	14,115	—	—	SEC
IDERA PHARMACEUTICALS, INC.	Sep 30, 2022	OtherD (derivative)	1,343,547	—	—	SEC
Revance Therapeutics, Inc.	May 27, 2015	AwardD (derivative)	8,000	0.00 USD	—	SEC
Revance Therapeutics, Inc.	May 15, 2015	AwardD (derivative)	8,000	0.00 USD	—	SEC
Revance Therapeutics, Inc.	Apr 10, 2014	AwardD (derivative)	8,000	0.00 USD	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	2,039,382	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD (derivative)	-1,539,343	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	398,717	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD (derivative)	-398,717	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD (derivative)	-658,551	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	OtherD (derivative)	-500,039	—	—	SEC
Revance Therapeutics, Inc.	Feb 11, 2014	Other	658,551	—	—	SEC
QUINTILES TRANSNATIONAL CORP	Sep 29, 2003	OtherD (derivative)	-4,985	—	—	SEC
QUINTILES TRANSNATIONAL CORP	Sep 29, 2003	OtherD (derivative)	-3,883	—	—	SEC
QUINTILES TRANSNATIONAL CORP	Sep 29, 2003	OtherD (derivative)	-1,000	—	—	SEC
QUINTILES TRANSNATIONAL CORP	Sep 29, 2003	Other	-118.8	14.50 USD	$1.7K	SEC
QUINTILES TRANSNATIONAL CORP	Sep 29, 2003	OtherD (derivative)	-7,786	—	—	SEC
QUINTILES TRANSNATIONAL CORP	Sep 29, 2003	OtherD (derivative)	-80,000	—	—	SEC
QUINTILES TRANSNATIONAL CORP	Sep 29, 2003	OtherD (derivative)	-17,698	—	—	SEC
QUINTILES TRANSNATIONAL CORP	Sep 29, 2003	OtherD (derivative)	-19,947	—	—	SEC
QUINTILES TRANSNATIONAL CORP	Sep 29, 2003	OtherD (derivative)	-9,707	—	—	SEC